similar install problems
Greetings, I am novice as novice can be. I have a rudimentary knowledge of things UNIX, so understanding the error messages is currently difficult. I had a similar error wrt -m64. I removed that from the CFLAGS line and now have different errors. To whit:
Error code 127, which follows immediately after 2 lines that start "gcc" and two lines that appear to be instructing some change to
ar -cru libbwtgen.a bwt_gen.o QSufSort.o
and then the following Stop messages:
Stop in .../bwa-0.5.7/bwt_gen (line 18 of Makefile) Error code 1
Stop in..../bwa-0.5.7 (line 33 of Makefile)
Any help would be much appreciated!
-
Remove -m64 from the "CFLAGS" line in Makefile. Nonetheless, bwa works better on 64-bit machines.Leave a comment:
-
BWA installation failure
Hello World,
I downloaded the bwa version 5.7 and cannot compile it.
[Jurek@fg-pc22 bwa-0.5.7]$ make
make[1]: Entering directory `/home/Jurek/Desktop/bwa2/bwa-0.5.7'
make[1]: Nothing to be done for `lib'.
make[1]: Leaving directory `/home/Jurek/Desktop/bwa2/bwa-0.5.7'
make[1]: Entering directory `/home/Jurek/Desktop/bwa2/bwa-0.5.7/bwt_gen'
gcc -c -g -Wall -O2 -m64 -DHAVE_PTHREAD bwt_gen.c -o bwt_gen.o
bwt_gen.c:1: sorry, unimplemented: 64-bit mode not compiled in
make[1]: *** [bwt_gen.o] Error 1
make[1]: Leaving directory `/home/Jurek/Desktop/bwa2/bwa-0.5.7/bwt_gen'
make: *** [lib-recur] Error 1
What am I doing wrong (I appreciate it may be very simple)?
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Leave a comment: